353 related articles for article (PubMed ID: 10919885)
1. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.
Eskelin S; Pyrhönen S; Summanen P; Hahka-Kemppinen M; Kivelä T
Ophthalmology; 2000 Aug; 107(8):1443-9. PubMed ID: 10919885
[TBL] [Abstract][Full Text] [Related]
2. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanoma: implications of tumor doubling time.
Singh AD
Ophthalmology; 2001 May; 108(5):829-31. PubMed ID: 11319992
[No Abstract] [Full Text] [Related]
4. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
[TBL] [Abstract][Full Text] [Related]
5. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy.
Summanen P; Immonen I; Heikkonen J; Tommila P; Laatikainen L; Tarkkanen A
Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359
[TBL] [Abstract][Full Text] [Related]
8. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
[No Abstract] [Full Text] [Related]
9. Metastatic melanoma in the eye and orbit.
Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
[TBL] [Abstract][Full Text] [Related]
10. Invited commentary. Uveal melanoma: implications of tumor doubling time.
O'Brien J
Ophthalmology; 2001 May; 108(5):831-2. PubMed ID: 11780648
[No Abstract] [Full Text] [Related]
11. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
12. Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture.
Grossniklaus HE
JAMA Ophthalmol; 2013 Apr; 131(4):462-9. PubMed ID: 23392528
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of liver metastases from uveal melanoma.
Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
[TBL] [Abstract][Full Text] [Related]
14. Uveal melanoma: a rare malignancy.
Gragoudas ES; Egan KM
Ophthalmology; 2000 Aug; 107(8):1441-2. PubMed ID: 10919884
[No Abstract] [Full Text] [Related]
15. Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy.
Kodjikian L; Grange JD; Rivoire M
Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):622-4. PubMed ID: 15650857
[TBL] [Abstract][Full Text] [Related]
16. Small metastasizing choroidal melanomas.
Malclès A; Kivelä T; Svetlosakova Z; Jean-Louis B; Nguyen AM; Sallit R; Négrier S; Pommier P; Rivoire M; Chauvel P; Mammar H; Devouassoux-Shisheboran M; Kodjikian L; Denis P; Grange JD
Acta Ophthalmol; 2015 Mar; 93(2):e160-6. PubMed ID: 25124923
[TBL] [Abstract][Full Text] [Related]
17. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
Zheng J; Irani Z; Lawrence D; Flaherty K; Arellano RS
J Vasc Interv Radiol; 2018 Oct; 29(10):1369-1375. PubMed ID: 30174161
[TBL] [Abstract][Full Text] [Related]
18. Variates of survival in metastatic uveal melanoma.
Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
[TBL] [Abstract][Full Text] [Related]
19. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.
Vogl T; Eichler K; Zangos S; Herzog C; Hammerstingl R; Balzer J; Gholami A
J Cancer Res Clin Oncol; 2007 Mar; 133(3):177-84. PubMed ID: 17021903
[TBL] [Abstract][Full Text] [Related]
20. Delayed systemic recurrence of uveal melanoma.
Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
